DGAP-Ad-hoc: Heidelberger Druckmaschinen AG / Key word(s): Personnel
The Supervisory Board of Heidelberger Druckmaschinen Aktiengesellschaft appointed in its meeting today Dr Ludwin Monz (58) effective as of 01 April 2022 as Chairman of the Management Board of the Company. Dr Monz currently is chairman of Carl Zeiss Meditec AG. He will succeed Rainer Hundsdörfer, who will step down from his office as Chairman of the Management Board on 31 March 2022, as per the end of the financial year. Furthermore, the Supervisory Board plans to extend the appointment of Marcus Antonius Wassenberg as member of the Management Board and Chief Financial Officer and labor director (Arbeitsdirektor) until 2027. Contact: Heidelberger Druckmaschinen AG Corporate Public Relations Thomas Fichtl Phone: +49 (0)6222 82-67123 Fax: +49 (0)6222 82-67129 E-mail: thomas.fichtl@heidelberg.com Investor Relations Maximilian Beyer Phone: +49 (0)6222 82-67120 Fax: +49 (0)6222 82-99 67120 E-Mail: maximilian.beyer@heidelberg.com
28-Oct-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Heidelberger Druckmaschinen AG |
Kurfürsten-Anlage 52-60 | |
69115 Heidelberg | |
Germany | |
Phone: | +49 (0)6222 82-67121 |
Fax: | +49 (0)6222 82-67129 |
E-mail: | investorrelations@heidelberg.com |
Internet: | www.heidelberg.com |
ISIN: | DE0007314007 |
WKN: | 731400 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1244549 |
End of Announcement | DGAP News Service |
|
1244549 28-Oct-2021 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.